PackTalk is a blog for the Healthcare Packaging Industry

Treating Disease at the Speed of Life?

“It’s very much a change. In areas of high unmet need, FDA seems to be committed to getting medicines to these people as fast as possible.”

–Alethia Young, biotechnology analyst, Cantor Fitzgerald


As the EU MDR full roll-out readies for enforcement in March and ISO 11607-2 new packaging requirements threaten to extend launch timelines, teams everywhere are trying to quantify the impact. Yet, just as we discuss “how much longer,” a story comes along that seems to upend our focus.

In this case, the story centers around the surprisingly fast pace at which the FDA is approving new drugs—touting the potential benefits for people living with rare or untreatable diseases.  The first example is Global Blood Therapeutics Inc.’s Oxbryta sickle cell disease drug, which passed Go three months ahead of schedule in 2019. Informal calculations noted if a standard medicine takes 10 months for an FDA ruling, certain drugs like those in the high unmet need category showed five medicines approved “in as little as eight weeks.”

So, should we be happy or concerned? The story gives a nod to biotechnology breakthroughs and genetic science as yielding more precise data, for one. Yet, patient safety watchdogs are wary, concerned that speed can kill. Patients who might receive these therapies are dismissive, even elated. When you have no viable options, there is nothing to lose and potentially everything to gain.

Those of us who work with drug makers on a daily basis should remain committed to safety and compliance regardless of requirements that may lengthen the journey. We should follow the unfolding outcomes of medicines and devices that receive these fast-track approvals. The Bloomberg story explores several avenues of consideration for this high-speed trend. All worth pondering, even if it's too soon to know how the story ends.


Comments (0)

Related Articles

Pulling Together To Fight COVID-19

Thermo Fisher Scientific, Mayo Clinic, and Roche Get FDA Approval to Help in Fight Against COVID-19.

As we all pull together in the fight against COVID-19, it is encouraging to read details about the FDA’s fast tracking of COVID-19 diagnostic tests under...

Learn More

COVID-19 Update

To Our Valued Customers:

First, let me begin by saying this: I hope you and your families, friends, and colleagues are safe and healthy during this challenging time. I recognize that many in the healthcare community are fighting COVID-19 from the front lines,...

Learn More

Seal Strength Testing: Is 1 lb. Still the Go-To Metric? ASTM WK57656 Update

A few years ago, I started a journey on behalf of packaging professionals everywhere—to validate or debunk the 1 lb. standard for seal strength testing. For as long as I can remember, it has been a popular topic of conversation and debate in every gathering...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.